Novel mutations in the BRCA1 and BRCA2genes in Iranian women with early-onset breast cancer

Breast Cancer Research

Volumn 4, Issue 4, 2002, Pages

  Yassaee, Vahid R ^a,b   Zeinali, Sirous ^c   Harirchi, Iraj ^d   Jarvandi, Soghra ^d   Mohagheghi, Mohammad A ^d   Hornby, David P ^a   Dalton, Ann ^b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

^c PASTEUR INSTITUTE OF IRAN   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

BRCA1; BRCA2; Breast cancer; Iranian population; Mutation detection methods

Indexed keywords

ADULT; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; EARLY CANCER; EXON; FAMILY HISTORY; FEMALE; FRAMESHIFT MUTATION; GENE AMPLIFICATION; GENE IDENTIFICATION; GENE MUTATION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC SCREENING; HUMAN; IRAN; IRANIAN PEOPLE; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; OVARY CANCER; POLYMERASE CHAIN REACTION; POPULATION GENETICS; POPULATION RESEARCH; TUMOR SUPPRESSOR GENE; BREAST NEOPLASMS; COMPARATIVE STUDY; GENETIC PREDISPOSITION; GENETICS; GERMLINE MUTATION; MISSENSE MUTATION; MOLECULAR GENETICS; NEOPLASTIC SYNDROMES, HEREDITARY; ONSET AGE; SINGLE STRAND CONFORMATION POLYMORPHISM; STOP CODON; UNITED KINGDOM;

DNA; STOP CODON;

ADULT; AGE OF ONSET; BREAST NEOPLASMS; CODON, NONSENSE; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; EXONS; FEMALE; FRAMESHIFT MUTATION; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; GREAT BRITAIN; HUMANS; IRAN; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; NEOPLASTIC SYNDROMES, HEREDITARY; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL;

EID: 34250896452     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr443     Document Type: Article

References (39)

1. Marcus JN, Watson P, Page DL, Narod SA, Lenoir GM, Tonin P, Linder-Stephenson L, Salerno G, Conway TA, Lynch HT: Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer. 1996, 77: 697-709. 10.1002/(SICI)1097-0142(19960215)77:4<697::AID-CNCR16>3.0.CO;2-W.
2. Easton D: Breast cancer genes - what are the real risks?. Nat Genet. 1997, 16: 210-211.
3. Parker SL, Tong T, Bolden S, Wingo PA: Cancer statistics. Cancer J Clin. 1997, 47: 5-27.
4. GLOBACAN 2000: Cancer Incidence, Mortality and Prevalance Worldwide, Ver 1.0, IARC CancerBase No 5. Lyon: IARC Press. 2001
5. Mosavi-Jarrahi A, Mohaghghi MA, Zeraatti H, Mortazavi H: Cancer registration in Iran. Asian Pacif J Cancer Prev. 2001, 2: 25-29.
6. UK National Statistics. 2002, [http://www.statistics.gov.uk/]
7. Newman B, Austin MA, Lee M, King M-C: Inheritance of human breast cancer: evidence for autosomal dominant transmission in high risk families. Proc Natl Acad Sci USA. 1988, 85: 3044-3048.
8. Tabar L, Duffy SW, Vitak B, Chen H-H, Prevost TC: The natural history of breast carcinoma. Cancer. 1999, 86: 449-462. 10.1002/(SICI)1097-0142(19990801)86:3<449::AID-CNCR13>3.3.CO;2-H.
9. Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, King M-C: Linkage of early-onset familial breast cancer to chromosome 17q21. Science. 1990, 250: 1684-1689.
10. Miki Y, Swensen J, Shattuck-Eidens D, Futreal AP, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett ML, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A, Skolnick MH: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA. Science. 1994, 266: 66-71.
11. Wooster R, Neuhausen SL, Mangion J, Quirk Y: Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q 12-13. Science. 1994, 265: 2088-2090.
12. Langston AA, Malone KE, Thompson JD, Daling JR, Ostrander EA: BRCA1 mutations in a population-based sample of young women with breast cancer. New Engl J Med. 1996, 334: 137-142. 10.1056/NEJM199601183340301.
13. Struewing JP, Abeliovich D, Peretz T, Avishai N: The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet. 1995, 11: 198-200.
14. Thorlacius S, Olafsdottir G, Tryggvadottir L, Neuhausen S, Jonasson JG, Tavtigian SV, Tulinius H, Oegmundsdottir HM, Eyfjoerd JE: A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat Genet. 1996, 13: 117-119.
15. Fitzgerald MG, MacDonald DJ, Krainer M, Hoover I, O'Neil E, Unsal H, Silva-Arrieto S, Finkelstein DM, Beer-Romero P, Englert C: Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. N Engl J Med. 1996, 334: 143-149. 10.1056/NEJM199601183340302.
16. Breast Cancer Information Core (BIC). 2001, [http://www.nhgri.nih.gov/Intramural_research/Lab_transfer/Bic]
17. Easton DF, Bishop T, Ford D, Crockford GP, the Breast Cancer Linkage Consortium: Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am J Hum Genet. 1993, 52: 678-701.
18. Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C: BRCA1 mutations in primary breast and ovarian carcinomas. Science. 1994, 266: 120-122.
19. Merajver SD, Pham TM, Caduff RF, Chen M, Poy EL, Cooney KA, Weber BL, Collins FS, Johnston C, Frank TS: Somatic mutations in the BRCA1 gene in sporadic ovarian tumours. Nat Genet. 1995, 9: 439-443.
20. Weber BHF, Brohm M, Stec I, Backe J, Caffier H: A somatic truncating mutation in BRCA2 in a sporadic breast tumor. Am J Hum Genet. 1996, 59: 962-964.
21. Roest P, Roberts R, Sugino S, van Ommen GJB, den Dunnen JT: Protein truncation test (PTT) for rapid detection of translation-terminating mutations. Hum Mol Genet. 1993, 2: 1719-1721.
22. Van Der Luijt RB, Meera Kahn P, Vasen H, Van Leeuwen C, Tops C, Roest PAM, Den Dunnen JT, Fodde R: Rapid detection of translation-terminating mutations at the adenomatous polyposis coli (APC) gene by direct protein truncation test. Genomics. 1994, 20: 1-4. 10.1006/geno.1994.1119.
23. Hogervorst FB, Cornelis RS, Bout M, van Vliet M, Oosterwijk JC, Olmer R, Bakker B, Klijn JG, Vasen HF, Meijers-Heijboer H: Rapid detection of BRCA1 mutations by the protein truncation test. Nat Genet. 1995, 10: 208-212.
24. Orita M, Suzuki Y, Sekiya T, Hayashi K: Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics. 1989, 5: 874-879.
25. Gayther SA, Harrington P: Rapid detection of regionally clustered germ-line BRCA1 mutations by multiplex heteroduplex analysis. Am J Hum Genet. 1996, 58: 451-456.
26. Wu LC, Wang ZW, Tsan JT, Spillman MA, Phung A, Xu XL, Yang MC, Hwang LY, Bowcock AM, Baer R: Identification of a RING protein that can interact in vivo with the BRCA1 gene product. Nat Genet. 1996, 14: 430-440.
27. Zhang X, Moréra S, Bates PA, Whitehead PC, Coffer AI, Hainbucher K, Nash RA, Sternberg MJE, Lindahl T, Freemont PS: Structure of an XRCC1 BRCT domain: a new protein-protein interaction module. EMBO J. 1998, 17: 6404-6411. 10.1093/emboj/17.21.6404.
28. Shattuck-Eidens D, McClure M, Simard J, Labrie F, Narod S, Couch F: A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene: implications for presymptomatic testing and screening. JAMA. 1995, 273: 535-541. 10.1001/jama.273.7.535.
29. Gayther SA, Warren W, Mazoyer S, Russell PA, Harrington PA, Chiano M, Seal S, Hamoudi R, Van Rensburg EJ, Dunning AM, Love R, Evans G, Easton D, Clayton D, Stratton MR, Ponder BAJ: Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a gonotype-phenotype correlation. Nat Genet. 1995, 11: 428-433.
30. Serova O, Montagna M, Torchard D, Narod SA, Tonin P, Sylla B, Lynch HT, Feunteun J, Lenoir GM: A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families. Am J Hum Genet. 1996, 58: 42-51.
31. Peelen T, van Vliet M, Petrij-Bosch A, Mieremet R, Szabo C, van den Ouweland AMW, Hogervorst F, Brohet R, Ligtenberg MJL, Teugels E, van der Luijt R, van der Hout AH, Gille JJP, Pals G, Jedema I, Olmer R, van Leeuwen I, Newman B, Plandsoen M, van der Est M, Brink G, Hageman S, Arts PJW, Bakker MM, Willems HW, van der Looij E, Neyns B, Bonduelle M, Jansen R, Oosterwijk JC, Sijmons R, Smeets HJM, van Asperen CJ, Meijers-Heijboer H, Klijn JGM, de Greve J, King M-C, Menko FH, Brunner HG, Halley D, van Ommen G-JB, Vasen HFA, Cornelisse CJ, van't Veer LJ, de Knijff P, Bakker E, Devilee P: A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families. Am J Hum Genet. 1997, 60: 1041-1049.
32. Schubert EL, Lee MK, Mefford HC, Argonza RH, Morrow JE, Hull J, Dann JL, King MC: BRCA2 in American families with four or more cases of breast or ovarian cancer: recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 or BRCA2. Am J Hum Genet. 1997, 60: 1031-1040.
33. 4. Nature. 1970, 227: 680-685.
34. Malone KE, Daling JR, Thompson JD, O'Brien CA, Francisco LV, Ostrander EA: BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first-degree family history. JAMA. 1998, 279: 922-929. 10.1001/jama.279.12.922.
35. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BA, Gayther SA, Zelada-Hedman M, Breast Cancer Linkage Consortium: Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet. 1998, 62: 676-689. 10.1086/301749.
36. Gayther SA, Russell P, Harrington P, Antoniou AC, Easton DF, Ponder BAJ: The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer: no evidence for other ovarian cancer-susceptibility genes. Am J Hum Genet. 1999, 65: 1021-1029. 10.1086/302583.
37. Peto J, Collins N, Barfoot R, Seal S, Warren W, Rahman N, Easton DF, Evans C, Deacon J, Michael R: Prevalence of BRCA1 and PRCA2 gene mutation in patients with early-onset breast cancer. J Nat Cancer Inst. 1999, 91: 943-949. 10.1093/jnci/91.11.943.
38. Neave HR: In Statistics Tables for Mathematicians, Engineers, Economists and the Behavioural and Management Sciences. London, Unwin Hyman Ltd. 1988, 7-28.
39. Easton D: Breast cancer - not just whether but when?. Nat Genet. 2000, 26: 390-391. 10.1038/82495.